Your browser doesn't support javascript.
loading
Identifying Opportunities to Improve Patient Experience With Sacral Neuromodulation: A Human Factors Approach.
Cohen, Tara N; Cohen, Kate A; Burton, Claire S; Kanji, Falisha F; Francis, Sarah E; Patel, Deven C; Ackerman, A Lenore; Eilber, Karyn S; Anger, Jennifer T.
Afiliação
  • Cohen TN; Cedars-Sinai Medical Center, Department of Surgery, Los Angeles, CA. Electronic address: tara.cohen@cshs.org.
  • Cohen KA; Cedars-Sinai Medical Center, Department of Surgery, Los Angeles, CA.
  • Burton CS; University of California Los Angeles, Department of Urology, Los Angeles, CA.
  • Kanji FF; Cedars-Sinai Medical Center, Department of Surgery, Los Angeles, CA.
  • Francis SE; Cedars-Sinai Medical Center, Department of Perioperative Services, Los Angeles, CA.
  • Patel DC; Cedars-Sinai Medical Center, Department of Surgery, Los Angeles, CA.
  • Ackerman AL; Cedars-Sinai Medical Center, Department of Surgery, Los Angeles, CA.
  • Eilber KS; Cedars-Sinai Health System, Department of Surgery, Division of Urology, Los Angeles, CA.
  • Anger JT; Cedars-Sinai Health System, Department of Surgery, Division of Urology, Los Angeles, CA.
Urology ; 150: 207-212, 2021 04.
Article em En | MEDLINE | ID: mdl-32389820
ABSTRACT

OBJECTIVES:

To use a human factors approach to conduct a needs assessment of patient preparedness, education, device usability, and satisfaction regarding all stages of sacral neuromodulation therapy and identify opportunities for improvement. Sacral neuromodulation, though minimally invasive, involves an initial testing phase that requires active patient participation. This process is relatively complex and, if a patient does not receive adequate preprocedure education, can be difficult to conceptualize. MATERIALS AND

METHODS:

Candidates were recruited to participate before undergoing staged sacral neuromodulation. Ten patients were observed, and their experiences were evaluated at 4 phases (1) date of test implant (Stage I), (2) 5 days following Stage I, (3) date of permanent implant (Stage II), and (4) 3 months following Stage II. Administered questionnaires focused on preoperative preparedness, postoperative satisfaction, and usability.

RESULTS:

While every patient reported that their symptoms were at least "a little better" postoperatively, they generally had difficulty understanding the risks of the planned procedure, did not know what to expect postoperatively and were unsatisfied with the preoperative materials. Patients struggled with adjusting the settings for their implant devices and usability was considered "below average." Despite overall objective success, 30% of patients indicated that they would not recommend this treatment to friends/family.

CONCLUSION:

This pilot needs analysis demonstrates several opportunities for improvement in the experience of patients undergoing sacral neuromodulation. These findings highlight the opportunities for a multifaceted intervention to improve patient understanding through the testing phase.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Terapia por Estimulação Elétrica / Satisfação do Paciente / Bexiga Urinária Hiperativa Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Urology Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Terapia por Estimulação Elétrica / Satisfação do Paciente / Bexiga Urinária Hiperativa Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Urology Ano de publicação: 2021 Tipo de documento: Article